![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CARDIOVASCULAR
Department of Pharmacology, University of Nebraska Medical Center, Omaha, Nebraska (K.R.B.); Departments of Pharmacology and Toxicology, Medicine, and Center for Vascular Biology, Indiana University School of Medicine, Indianapolis, Indiana (H.R.B.); and Department of Pharmacology, Faculty of Pharmacy, University of Ankara, Tandogan, Ankara, Turkey (U.D.D.)
In a previous study, we showed that after 6 weeks of streptozotocin-induced
diabetes (6D), expression of type 2 ryanodine receptor calcium-release
channels (RyR2) did not change significantly in rat hearts. However, the
ability of this protein to bind [3H]ryanodine was compromised. Loss
in activity therefore resulted from diabetes-induced increases in
post-translational modifications on RyR2. In the present study, the effects of
diabetes on one type of modification, namely, changes in oxidative state of
reactive sulfhydryls was investigated. RyR2 protein from 6D bound 42.3
± 7.6 less [3H]ryanodine than RyR2 from controls (6C). The
loss in binding was minimized with 2 weeks of insulin treatment initiated
after 4 weeks of diabetes (77.8 ± 5.5% of 6C). Pretreating RyR2 from 6D
with 2 mM dithiothreitol in vitro increases [3H]ryanodine binding
by 60.8 ± 5.3%. Dithiothreitol pretreatment of RyR2 from 6C increased
[3H]ryanodine binding by 16.8 ± 4.3%. The reagent pyrocoll
interacts with distinct classes of free sulfhydryl groups on 6C RyR2 to induce
two major effects. At concentrations
10 µM, it deactivates RyR2
(decreases [3H]ryanodine binding), whereas at higher concentrations
it activates them (increases [3H]ryanodine binding). This reagent
was unable to activate RyR2 from 6D. Although RyR2 from insulin-treated
animals was deactivated by low concentrations of pyrocoll, it was only
partially activated at higher concentrations. These data suggest that the
dysfunction of RyR2 induced by diabetes may be due in part to formation of
disulfide bonds between adjacent sulfhydryl groups and that these changes were
attenuated with insulin treatment.
Address correspondence to: Dr. Keshore R. Bidasee, Department of Pharmacology, University of Nebraska Medical Center, 986260 Nebraska Medical Center, Omaha, NE 68198-6260. E-mail: kbidasee{at}unmc.edu
This article has been cited by other articles:
![]() |
N. Yaras, M. Ugur, S. Ozdemir, H. Gurdal, N. Purali, A. Lacampagne, G. Vassort, and B. Turan Effects of Diabetes on Ryanodine Receptor Ca Release Channel (RyR2) and Ca2+ Homeostasis in Rat Heart Diabetes, November 1, 2005; 54(11): 3082 - 3088. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, Z. Xu, S. Li, and G. J. Rozanski Redox regulation of Ito remodeling in diabetic rat heart Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1417 - H1424. [Abstract] [Full Text] [PDF] |
||||